RAPT Therapeutics Statistics

Total Valuation

RAPT has a market cap or net worth of $285.69 million. The enterprise value is $121.55 million.

Market Cap	285.69M
Enterprise Value	121.55M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

RAPT has 34.80 million shares outstanding. The number of shares has increased by 17.82% in one year.

Shares Outstanding	34.80M
Shares Change (YoY)	+17.82%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	1.85%
Owned by Institutions (%)	102.60%
Float	27.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.86
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.41, with a Debt / Equity ratio of 0.05.

Current Ratio	7.41
Quick Ratio	n/a
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -63.10% and return on invested capital (ROIC) is -82.54%.

Return on Equity (ROE)	-63.10%
Return on Assets (ROA)	-55.50%
Return on Capital (ROIC)	-82.54%
Revenue Per Employee	n/a
Profits Per Employee	-$891,588
Employee Count	131
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.08% in the last 52 weeks. The beta is 0.47, so RAPT's price volatility has been lower than the market average.

Beta (1Y)	0.47
52-Week Price Change	-58.08%
50-Day Moving Average	10.63
200-Day Moving Average	16.98
Relative Strength Index (RSI)	36.37
Average Volume (30 Days)	1,366,956

Short Selling Information

The latest short interest is 2.98 million, so 8.55% of the outstanding shares have been sold short.

Short Interest	2.98M
Short Previous Month	3.30M
Short % of Shares Out	8.55%
Short % of Float	10.82%
Short Ratio (days to cover)	2.55

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-127.06M
Pretax Income	-116.80M
Net Income	-116.80M
EBITDA	-113.25M
EBIT	-116.80M
Earnings Per Share (EPS)	-$3.05

Full Income Statement

Balance Sheet

The company has $158.86 million in cash and $6.91 million in debt, giving a net cash position of $151.96 million or $4.37 per share.

Cash & Cash Equivalents	158.86M
Total Debt	6.91M
Net Cash	151.96M
Net Cash Per Share	$4.37
Equity / Book Value	147.04M
Book Value Per Share	4.23
Working Capital	139.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$97.05 million and capital expenditures -$1.13 million, giving a free cash flow of -$98.17 million.

Operating Cash Flow	-97.05M
Capital Expenditures	-1.13M
Free Cash Flow	-98.17M
FCF Per Share	-$2.56

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RAPT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.82%
Shareholder Yield	-17.82%
Earnings Yield	-42.70%
FCF Yield	-35.89%

Analyst Forecast

The average price target for RAPT is $22.29, which is 171.83% higher than the current price. The consensus rating is "Buy".

Price Target	$22.29
Price Target Difference	171.83%
Analyst Consensus	Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2